Recombinant Human MGAT2 Protein，His & Myc

MGAT2, or Mono-1,4-mannosyl-glycoprotein 2-N-acetylglucosaminyltransferase, is an essential enzyme involved in the biosynthesis of complex N-glycans, playing a critical role in glycoprotein maturation. This enzyme catalyzes the transfer of N-acetylglucosamine (GlcNAc) to the mannose residue of glycoproteins, influencing their structural integrity and functional properties. Research on MGAT2 is driven by its significance in cellular processes, including protein folding, cell signaling, and immune response regulation. Aberrant glycosylation patterns due to MGAT2 dysregulation have been implicated in various diseases, including cancer, where altered glycan structures can affect tumor progression and metastasis. Additionally, the potential of MGAT2 as a therapeutic target has garnered attention, making the study of its recombinant protein increasingly important. By producing and analyzing MGAT2 recombinant proteins, researchers aim to elucidate the enzyme's activity, substrate specificity, and structural characteristics, ultimately seeking to develop strategies for modulating glycan synthesis in disease contexts. The exploration of MGAT2 not only enhances our understanding of glycosylation and its biological implications but also paves the way for innovative therapeutic interventions that could leverage glycan engineering to combat diseases associated with glycoprotein anomalies. This research holds promise for advancing both basic science and clinical applications in glycobiology and therapeutic development.